Analysis of the number of hospitalizations and hospitalization cost factors in Alteplase Thrombolysis-Treated Cerebral Infarction Patients from 2021 to 2022
Objectives This study aims to analyze factors affecting hospitalization costs,so as to provide a reference for the prevention and treatment of acute cerebral infarction in the region and provide a basis for reducing the economic burden of such patients.Methods The hospitalization cost data for patients with acute cerebral infarction who underwent alteplase intravenous thrombolysis in the Department of Neurology from January 1,2021,to December 31,2022,in a certain hospital were utilized.The enumeration data were analyzed using a chi-square test,and multiple stepwise regression analysis was performed on the influencing factors of hospitalization expenses.Results Alteplase thrombolysis patients accounted for 9.98％of patients with acute cerebral infarction.When considering the age distribution of thrombolysis patients,the majority falled between 60 and 79 years old,while the fewest were in the 30 to 39-year-old group.The gender distribution showed that 68.88％were male and 31.12％were female.The total effective rate of thrombolysis was 73.4％.The average length of stay for patients with thrombolysis was 7.44±5.99 days,with an average cost per time of 16808.21±13931.39 yuan.Conclusions The length of hospitalization,efficacy,complications or complications after thrombolysis,age,and gender are factors that affect the total hospitalization cost.Corresponding measures should be implemented to control the average length of stay,reduce transfer and discharge rates,and enhance the efficiency of thrombolysis.This will help control the cost of thrombolytic treatment and alleviate the economic burden on patients with acute cerebral infarction.
万方数据
维普
